15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 12 firms covering NOV Inc, 3 rate it Buy or better, 7 sit at Hold, and 2 rate it Sell or worse, a hold consensus. Targets span $15.00 to $23.00, a moderate spread. The average target of $20.58 sits 4% above the current $19.80. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.25 next quarter toward $1.27 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS12 ratings
Hold
Strong Buy00%
Buy325%
Hold758%
Sell217%
Strong Sell00%
Based on 12 analysts giving stock ratings to NOV Inc.
As of Jul, 3 of 11 firms rate NOV a Buy (6 Hold, 2 Sell), the standing distribution of every covering firm's most recent active call.
NOV EPS & revenue forecast
EPS · NEXT QUARTER
$0.25
Range $0.16 – $0.31 · 13 analysts · +125% YoY
Next period, 13 analysts expect NOV Inc. to earn $0.25 a share (range $0.16 – $0.31), versus $0.11 a year earlier. Full-year consensus is $0.80, growing to $1.27 the year after.
REVENUE · NEXT QUARTER
$2.2B
Range $2.1B – $2.3B · 13 analysts · +0% YoY
Revenue is expected to reach $2.2B (range $2.1B – $2.3B), +0.2% year-over-year. Full-year consensus is $8.6B, rising to $9.1B next year.
Top analysts covering NOV Inc.
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on NOV.
#1
Scott Gruber
Citigroup · Rank #13
Hold
$22.00+11.1% to target
Overall win rate
58%
+ Follow
#2
Roger Read
Wells Fargo · Rank #24
Sell
$10.00-49.5% to target
Overall win rate
49%
+ Follow
#3
Neil Mehta
Goldman Sachs · Rank #59
Sell
$20.00+1.0% to target
Overall win rate
42%
+ Follow
#4
Stephen Gengaro
Stifel · Rank #169
Buy
$23.00+16.2% to target
Overall win rate
38%
+ Follow
#5
David Anderson
Barclays · Rank #175
Sell
$21.00+6.1% to target
Overall win rate
44%
+ Follow
NOV stock forecast FAQ
What is NOV's average 12-month price target?+
The 12 analysts with a live target average $20.58 for NOV Inc. over the next 12 months, ranging from a $23.00 high to a $15.00 low.
Is NOV stock a Buy, Sell or Hold right now?+
The current consensus is Hold. Of the 12 analyst ratings, 3 are Buy or Strong Buy, 7 are Hold, and 2 are Sell or Strong Sell.
What are the highest and lowest price targets for NOV?+
The Street-high target is $23.00 (Stifel), and the Street-low is $15.00 (JP Morgan). The average of all 12 active targets is $20.58.
How many Wall Street analysts cover NOV?+
12 analysts have an active rating on NOV Inc., and 12 firms carry a live 12-month price target.
Who is the most accurate analyst covering NOV?+
Among analysts who currently cover NOV, Scott Gruber of Citigroup has the strongest overall Quantellect track record (Rank #13). Their current call is Hold with a $22.00 target.
What is NOV Inc.'s projected EPS for next quarter?+
The consensus estimate is $0.25 per share (range $0.16 – $0.31) across 13 analysts. Full-year EPS is projected at $0.80, rising to $1.27 the following year.
How much revenue is NOV Inc. expected to report next quarter?+
Consensus revenue is $2.2B (range $2.1B – $2.3B). Full-year revenue is projected at $8.6B, growing to $9.1B next year.
Have analysts been upgrading or downgrading NOV lately?+
As of Jul, 3 of 11 firms rate NOV a Buy (6 Hold, 2 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their NOV calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
